Electroceuticals: Reinventing Chronic Disease Care Without Drugs
Frost & Sullivan Podcasts
In this episode of Frost & Sullivan’s Growth Podcast, we explore how electroceuticals are transforming chronic disease management—from pain to neurodegeneration. With wearable formats, AI-driven personalization, and hybrid therapy models, this market is scaling fast and redefining long-term care.
🎯 Key takeaways include:
• How electroceuticals offer scalable, non-invasive alternatives to chronic drug use
• Role of AI in driving real-time therapy optimization and patient-specific outcomes
• Top innovators including Boston Scientific, Sinaptica, and Nalu Medical
• Why multimodal systems are the next leap in non-pharmacological care
• Business and investment opportunities shaping the bioelectronic medicine frontier
This episode is essential for leaders across medtech, digital therapeutics, and chronic care innovation.
frost.com | hello@frost.com
Loading